Results 111 to 120 of about 5,502 (184)

Pharmacodynamics and Pharmacokinetics of Higher-Dose, Double-Bolus Eptifibatide in Percutaneous Coronary Intervention [PDF]

, 2001
Ian C. Gilchrist, J.Conor O’Shea, Teddy Kosoglou, Lisa K. Jennings, Todd J. Lorenz, Michael M. Kitt, Neal S. Kleiman, David Talley, Frank Aguirre, Charles J. Davidson, John Paul Runyon, James E. Tcheng   +11 more
openalex   +1 more source

The Impact of Cangrelor in the UK for the Treatment of STEMI Patients with Gastric Absorption Issues Undergoing Percutaneous Coronary Intervention. [PDF]

J Clin Med
Modi B, Cain R, Stork R, Tarpey G, Colucciello A, Olivier D, Barwood C, Wright W, McAtamney R.   +8 more
europepmc   +1 more source

Emergency endovascular treatment of stroke due to cervical artery dissection - impact of periprocedural GP IIb/IIIa inhibitor use on clinical outcome. [PDF]

CVIR Endovasc
Sornalingam A, Wegener S, Stattmann M, Baumann J, Thurner P, Madjidyar J, Husain HS, Krepuska M, Globas C, Luft AR, Kulcsar Z, Schubert T.   +11 more
europepmc   +1 more source

RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms.

, 2017
Maryam Bavand Savadkouhi, Hossein Vahidi, Seyed Abdulmajid Ayatollahi, Shirin Hooshfar, Farzad Kobarfard   +4 more
openalex   +1 more source

Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes [PDF]

, 2002
Wayne Batchelor, Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R. Michael Mantell, Patricia Dillard, Marie Davidian, Daowen Zhang, Warren J. Cantor, Michael H. Sketch, E. Magnus Ohman, James P. Zidar, Daniel D. Gretler, Peter M. DiBattiste, James E. Tcheng, Robert M. Califf, Robert A. Harrington   +16 more
openalex   +1 more source

Thrombotic Occlusion in Coronary Ectasia Presenting as STEMI. [PDF]

JACC Case Rep
Ali M, Narendran R, Hasan F.
europepmc   +1 more source

The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

, 2017
Devraj Sukul, Milan Seth, Theodore Schreiber, George Hanzel, Akshay Khandelwal, Louis Cannon, Thomas LaLonde, Hitinder S. Gurm   +7 more
openalex   +2 more sources

Correction: Latacz et al. Safety and Efficacy of Low-Dose Eptifibatide for Tandem Occlusions in Acute Ischemic Stroke. <i>Neurol. Int.</i> 2024, <i>16</i>, 253-262. [PDF]

Neurol Int
Latacz P, Popiela T, Brzegowy P, Lasocha B, Kwiecień K, Simka M.   +5 more
europepmc   +1 more source

A Novel KGD-Based αIIbβ3 Antagonist Prevents Arterial Thrombosis While Preserving Hemostasis and Avoiding Thrombocytopenia. [PDF]

Int J Mol Sci
Kuo YJ, Chung CH, Chen CC, Liu JC, Chiou KR, Sheu JR, Chuang WJ, Huang TF.   +7 more
europepmc   +1 more source

Early eptifibatide improves TIMI 3 patency before primary percutaneous coronary intervention for acute ST elevation myocardial infarction: results of the randomized integrilin in acute myocardial infarction (INTAMI) pilot trial [PDF]

, 2005
Uwe Zeymer, Ralf Zahn, Rudolf Schiele, W Jansen, Ernst Girth, Anselm Gitt, Karlheinz Seidl, Rolf Schröder, Steffen Schneider, Jochen Senges   +9 more
openalex   +1 more source